Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers
- PMID: 20080664
- PMCID: PMC2836667
- DOI: 10.1073/pnas.0909797107
Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers
Abstract
The stromal compartment is increasingly recognized to play a role in cancer. However, its role in the transition from preinvasive to invasive disease is unknown. Most gastrointestinal tumors have clearly defined premalignant stages, and Barrett's esophagus (BE) is an ideal research model. Supervised clustering of gene expression profiles from microdissected stroma identified a gene signature that could distinguish between BE metaplasia, dysplasia, and esophageal adenocarcinoma (EAC). EAC patients overexpressing any of the five genes (TMEPAI, JMY, TSP1, FAPalpha, and BCL6) identified from this stromal signature had a significantly poorer outcome. Gene ontology analysis identified a strong inflammatory component in BE disease progression, and key pathways included cytokine-cytokine receptor interactions and TGF-beta. Increased protein levels of inflammatory-related genes significantly up-regulated in EAC compared with preinvasive stages were confirmed in the stroma of independent samples, and in vitro assays confirmed functional relevance of these genes. Gene set enrichment analysis of external datasets demonstrated that the stromal signature was also relevant in the preinvasive to invasive transition of the stomach, colon, and pancreas. These data implicate inflammatory pathways in the genesis of gastrointestinal tract cancers, which can affect prognosis.
Conflict of interest statement
Conflict of interest statement: J.S.H. and C.Z. are employees of Merck Laboratories.
Figures
Similar articles
-
Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma.Gastroenterol Clin North Am. 2002 Jun;31(2):461-79, ix. doi: 10.1016/s0889-8553(02)00013-4. Gastroenterol Clin North Am. 2002. PMID: 12134613 Review.
-
Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1380-5. doi: 10.1158/1055-9965.EPI-07-2734. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559552
-
Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.World J Gastroenterol. 2019 Jan 14;25(2):233-244. doi: 10.3748/wjg.v25.i2.233. World J Gastroenterol. 2019. PMID: 30670912 Free PMC article.
-
Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.Gastroenterol Clin North Am. 2015 Jun;44(2):299-315. doi: 10.1016/j.gtc.2015.02.005. Epub 2015 Mar 31. Gastroenterol Clin North Am. 2015. PMID: 26021196 Free PMC article. Review.
-
Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma.Clin Cancer Res. 2005 Apr 1;11(7):2478-85. doi: 10.1158/1078-0432.CCR-04-1280. Clin Cancer Res. 2005. PMID: 15814623
Cited by
-
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy.Genes Dev. 2016 May 1;30(9):1002-19. doi: 10.1101/gad.279737.116. Genes Dev. 2016. PMID: 27151975 Free PMC article. Review.
-
Turning foes to friends: targeting cancer-associated fibroblasts.Nat Rev Drug Discov. 2019 Feb;18(2):99-115. doi: 10.1038/s41573-018-0004-1. Nat Rev Drug Discov. 2019. PMID: 30470818 Review.
-
Thrombospondin-1 aggravates colonic mucosal inflammatory injuries via promoting the differentiation of CD11c+ macrophages with lysosomal activity limited in colitis.Ann Transl Med. 2021 Dec;9(23):1738. doi: 10.21037/atm-21-6034. Ann Transl Med. 2021. PMID: 35071432 Free PMC article.
-
Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.PLoS One. 2011;6(7):e22513. doi: 10.1371/journal.pone.0022513. Epub 2011 Jul 28. PLoS One. 2011. PMID: 21829465 Free PMC article.
-
Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients.Cancer Sci. 2013 Apr;104(4):437-44. doi: 10.1111/cas.12096. Epub 2013 Feb 21. Cancer Sci. 2013. PMID: 23298232 Free PMC article.
References
-
- Marx J. Cancer biology. All in the stroma: Cancer’s Cosa Nostra. Science. 2008;320:38–41. - PubMed
-
- Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30:1073–1081. - PubMed
-
- Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392–401. - PubMed
-
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. - PubMed
-
- Maley CC, et al. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res. 2004;64:7629–7633. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous